FDA Adverse Event Malfunction Summary report: N

ARTEGRAFT AG640

MDR report key: 3123828 · Received May 15, 2013

Report

Report Number
2247686-2013-00001
Event Type
Malfunction
Date Received
May 15, 2013
Date of Event
April 17, 2013
Report Date
May 15, 2013
Manufacturer
ARTEGRAFT, INC.
Product Code
LXA
PMA / PMN Number
N16837
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ARTEGRAFT AG640, CONTROL #(B)(4), WAS DISCARDED AT THE HOSPITAL AFTER THE ATTEMPTED USE. EVALUATION OF THE ACTUAL MEDICAL DEVICE CANNOT BE COMPLETED. NO OTHER COMPLAINTS RECEIVED RELATED TO BATCH #(B)(4). (B)(4), HEALTH HAZARD ANALYSIS, AND FURTHER INVESTIGATION DOCUMENTATION HAVE BEEN INITIATED. RESULTS AND CONCLUSIONS WILL BE MAINTAINED WITHIN THE ARTEGRAFT COMPLAINT FILE #(B)(4).

Description of Event or Problem · 1

AN ARTEGRAFT DISTRIBUTOR WAS CONTACTED BY AN END-USER HOSPITAL REQUESTING CREDIT FOR AN ARTEGRAFT AG640, CONTROL #(B)(4). THE FIRST REPORT RECEIVED BY ARTEGRAFT, INC. INVOLVING ARTEGRAFT AG640, CONTROL #(B)(4) IS THAT THE DOCTOR DECIDED TO DISCARD THE IDENTIFIED GRAFT AFTER HE FOUND A HOLE IN THE GRAFT, AND HE FELT THE GRAFT LOOKED OF POOR QUALITY. THIS ORIGINAL HOLE WAS NOTICED DURING THE NORMAL SALINE IRRIGATION PROCESS PRIOR TO SURGERY. INFORMATION PROVIDED TO ARTEGRAFT, INC. AT A LATER TIME INDICATED THAT THE DOCTOR HAD REPAIRED THE ORIGINAL HOLE AND CONTINUED TO USE THE REPAIRED GRAFT FOR THE SURGERY. UPON ANASTOMOSIS, THE DOCTOR NOTICED A COUPLE MORE HOLES IN THE GRAFT THAT WERE NOT VISIBLE DURING THE PRE-SURGICAL FLUSHING PROCESS. AN ALTERNATE GRAFT WAS USED TO COMPLETE THE SURGERY. THE IDENTIFIED GRAFT WAS DISPOSED OF AT THE HOSPITAL AFTER THE SURGERY; THEREFORE, IT COULD NOT BE RETURNED TO ARTEGRAFT, INC. FOR FURTHER EVALUATION. NO ADDITIONAL COMPLAINTS HAVE BEEN RECEIVED RELATED TO BATCH #(B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
214870 ARTEGRAFT AG640 VASCULAR GRAFT LXA ARTEGRAFT, INC. AG640 13B036

Patients

Seq Age Sex Outcome Treatment
1